drug delivery

Research in the laboratory of Tejal Desai, PhD, is creating new kinds of drug delivery devices to reduce the scarring and inflammation that can undermine stents—metal mesh tubes implanted to prop open blocked arteries, including in the heart.

Faculty members in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, share their research on the human microbiome and microfabricated drug delivery systems and their hopes for how their science will improve the health of patients.

Drug delivery research led by UCSF’s Tejal Desai, PhD, will now be supported by an exclusive worldwide license agreement between UCSF and Zcube s.r.l.

Table of contents

Introduction
Budget significance
Reasons for past success
A decade of funding for bioinformatics
New drug discovery directions attract support
Research stalwarts draw funding for decades
New directions in translational research attract support
Expansion of the School’s...

UCSF scientists describe how their research is aiming to make therapeutics sophisticated, highly effective, and tailored to the different needs of individuals.

Kathy M. Giacomini, PhD, chair, department of biopharmaceutical sciences and Leslie Z. Benet, PhD, professor in the same department, were both honored at the Pharmaceutical Sciences World Congress, held May 29 to June 4, 2004 in Kyoto, Japan.

Leslie Z. Benet, PhD, was named a Thomson ISI Highly Cited Researcher in December 2003. The designation means that Benet's research publications on pharmacokinetics and pharmacodynamics have been extensively cited by other scientists in their publications. Citation is an important way to measure...